These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38987479)

  • 41. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.
    Tilhou AS; Dague L; Saloner B; Beemon D; Burns M
    JAMA Health Forum; 2022 Mar; 3(3):e220093. PubMed ID: 35977284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
    Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
    Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors Associated With Mortality Among Homeless Older Adults in California: The HOPE HOME Study.
    Brown RT; Evans JL; Valle K; Guzman D; Chen YH; Kushel MB
    JAMA Intern Med; 2022 Oct; 182(10):1052-1060. PubMed ID: 36036902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levels of engagement among office-based opioid treatment (OBOT) patients with concurrent methamphetamine use.
    Coules CL; Novotny CB; McDonough ME; Kopak AM
    Am J Addict; 2024 Sep; 33(5):583-589. PubMed ID: 38711245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
    Wakeman SE; Larochelle MR; Ameli O; Chaisson CE; McPheeters JT; Crown WH; Azocar F; Sanghavi DM
    JAMA Netw Open; 2020 Feb; 3(2):e1920622. PubMed ID: 32022884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Housing Outcomes of Adults Who Were Homeless at Admission to Substance Use Disorder Treatment Programs Nationwide.
    Lo EA; Rhee TG; Rosenheck RA
    Psychiatr Serv; 2022 Aug; 73(8):872-879. PubMed ID: 35042395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk Factors for Falls in Older Adults Experiencing Homelessness: Results from the HOPE HOME Cohort Study.
    Abbs E; Brown R; Guzman D; Kaplan L; Kushel M
    J Gen Intern Med; 2020 Jun; 35(6):1813-1820. PubMed ID: 31965522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
    Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
    Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
    Frost MC; Zhang L; Kim HM; Lin LA
    JAMA Netw Open; 2022 Oct; 5(10):e2236298. PubMed ID: 36223118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study.
    Lakkadghatwala R; Lane D; Scheuermeyer F; Hilburt J; Buxton J; Johnson C; Nolan S; Sutherland C; Moe J; Daoust R; Dong K; Christenson J; Miles I; Orkin A; Whyte M; Kestler A
    Subst Abuse Treat Prev Policy; 2024 Feb; 19(1):14. PubMed ID: 38383467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Text message reminders for improving patient appointment adherence in an office-based buprenorphine program: A feasibility study.
    Tofighi B; Grazioli F; Bereket S; Grossman E; Aphinyanaphongs Y; Lee JD
    Am J Addict; 2017 Sep; 26(6):581-586. PubMed ID: 28799677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
    Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
    Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality Among Unsheltered Homeless Adults in Boston, Massachusetts, 2000-2009.
    Roncarati JS; Baggett TP; O'Connell JJ; Hwang SW; Cook EF; Krieger N; Sorensen G
    JAMA Intern Med; 2018 Sep; 178(9):1242-1248. PubMed ID: 30073282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic.
    Wakeman SE; McGovern S; Kehoe L; Kane MT; Powell EA; Casey SK; Yacorps GM; Irvin JR; Rodriguez W; Regan S
    J Subst Abuse Treat; 2022 Oct; 141():108848. PubMed ID: 35926256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.
    Hodgkin D; Horgan C; Bart G
    Addict Sci Clin Pract; 2021 Jul; 16(1):45. PubMed ID: 34225785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
    Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
    JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers.
    Schuman-Olivier Z; Albanese M; Nelson SE; Roland L; Puopolo F; Klinker L; Shaffer HJ
    J Subst Abuse Treat; 2010 Jul; 39(1):41-50. PubMed ID: 20434868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.
    Parlier-Ahmad AB; Pugh M; Martin CE
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1557-1567. PubMed ID: 34254271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.
    Hammerslag LR; Mack A; Chandler RK; Fanucchi LC; Feaster DJ; LaRochelle MR; Lofwall MR; Nau M; Villani J; Walsh SL; Westgate PM; Slavova S; Talbert JC
    JAMA Netw Open; 2023 Oct; 6(10):e2336914. PubMed ID: 37851446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.